Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support.

"We believe that 2025 will be a pivotal year for SELLAS as we continue to advance our clinical stage portfolio of novel therapeutics for hematologic malignancies,” said Angelos ...

New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights. COPENHAGEN, Denmark and PALO ALTO, Calif.

Glooko’s integration of Hedia’s diabetes tech aims to improve care for patients and enhance healthcare provider insights.

New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights. Glooko, Inc. and Hedia today announced the launch ...

Investors, entrepreneurs and digital health enthusiasts can breathe a sigh of relief. Digital health funding has normalized after a steady decrease in 2022 and 2023. Funding for venture-backed ...

Having diabetes means that controlling blood sugar when on the go was once a problem. Thankfully, in recent years, there have emerged many new types of health technology, which offer a great number of ...